Although anti- Vascular endothelial growth factor (VEGF) drugs and hormone drugs have been used in the treatment of DR in recent years, the treatment goal is mainly for diabetic macular edema, which requires long-term continuous administration. The gene discussed is VEGFA; the disease is diabetic macular edema.